A pH‐Responsive Biomimetic Antioxidant Nanoplatform with Dual Renal Targeting for Synergistic Therapy of Acute Kidney Injury
Advanced Science · 2026-01 · 13 (5)
DOI: 10.1002/advs.202515664 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 06.11.2025. Verfasst von Shichao Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin, 300211, China. Hauptthemen laut MEDLINE: Acute Kidney Injury, Antioxidants, Nanoparticles, Biomimetic Materials. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Education Commission Research Project of Tianjin, Talent support program of Tianjin institute of Urology, National Natural Science Foundation of China.
Abstract (Originalsprache)
Acute kidney injury (AKI) represents a critical clinical condition marked by abrupt deterioration of renal function, primarily driven by oxidative stress, inflammation, and apoptosis. However, effective targeted therapies remain limited. Here, a smart, biomimetic nanoplatform (CeAst@MK) that synergistically addresses oxidative and inflammatory injury in AKI is reported. CeAst nanoparticles are formed via coordination between Ce 3 ⁺ ions and astragalin (Ast), a natural flavonoid with intrinsic ROS‐scavenging and anti‐inflammatory properties. To enhance immune evasion and renal targeting specificity, CeAst is cloaked with macrophage membranes (MCM) and modified with a kidney‐targeting peptide (KTP), yielding the final CeAst@MK system. The platform exhibits pH‐responsive release in the acidic microenvironment of injured renal tissues, enabling precise and rapid therapeutic delivery. In both LPS‐ and ischemia reperfusion‐induced AKI models, CeAst@MK significantly improves renal function, suppresses proinflammatory cytokines, and promotes M2 macrophage polarization. Mechanistically, it modulates PI3K/Akt and NF‐κB pathways, achieving dual antioxidative and anti‐inflammatory effects. This study presents a translationally promising nanotherapeutic system integrating natural antioxidants, biomimetic camouflage, and tissue‐specific delivery, offering an effective and precise strategy for AKI intervention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Tianjin Institute of Urology, The Second Hospital of Tianjin Medical University, Tianjin, 300211, China.
- Intensive care unit, Institute of Infectious Diseases, The Second Hospital of Tianjin Medical University, Tianjin, 300211, China.
ORCID-Profile: Shiyong Qi
Förderung
- Education Commission Research Project of Tianjin
- Talent support program of Tianjin institute of Urology
- National Natural Science Foundation of China
- Science and Technology Project of Tianjin
Zitieren
APA
Zhang, S., Xie, Y., Zhang, L., Qi, Y., Liao, Q., Xu, C., Yang, S., Zhou, H., Tan, Q., & Qi, S. (2026). A pH‐Responsive Biomimetic Antioxidant Nanoplatform with Dual Renal Targeting for Synergistic Therapy of Acute Kidney Injury. Advanced Science, 13(5). https://doi.org/10.1002/advs.202515664
Vancouver
Zhang S, Xie Y, Zhang L, Qi Y, Liao Q, Xu C, et al. A pH‐Responsive Biomimetic Antioxidant Nanoplatform with Dual Renal Targeting for Synergistic Therapy of Acute Kidney Injury. Advanced Science. 2026;13(5). doi:10.1002/advs.202515664
BibTeX
@article{Zhang2026,
author = {Zhang, Shichao and Xie, Yuhan and Zhang, Longchao and Qi, Yuanjiong and Liao, Quan and Xu, Chenglong and Yang, Shushuai and Zhou, Haiwen and Tan, Qidan and Qi, Shiyong},
title = {A pH‐Responsive Biomimetic Antioxidant Nanoplatform with Dual Renal Targeting for Synergistic Therapy of Acute Kidney Injury},
journal = {Advanced Science},
year = {2026},
volume = {13},
number = {5},
doi = {10.1002/advs.202515664}
}
EUVIMED